The objects of these proposals are to establish the limits of metabolic adaptation in ischemic myocardium and to evaluate several interventions designed to improve energy production and/or mechanical function. We have observed previously that the damages of myocardial ischemia result not only from the loss in oxygen delivery, but also from an accumulation of several inhibitory metabolites. Nevertheless, manipulations which either modify or circumvent these products can be affected to stimulate residual oxidative phosphorylation. Studies in working swine hearts are planned to continue these investigations. Emphasis will be specifically directed at determining the effects of substrate enhancement, documenting the influence of agents designed to blunt the effects of fatty acid excess, and further detailing the impact of coronary washout. Alternate substrates which may have specific advantages in providing mitochondria with increased amount of acetyl-CoA and which will be evaluated in the coming grant year include: acetate, beta-hydroxybutyrate and pyruvate with dichloro acetate. Specific agents to be used in modifying fatty acid excess will be the various isomers (L, D and DL) of carnitine. Experiments will be formed to evaluate and determine the magnitude and distribution of the intracellular incorporation of carnitine, the effects of their isomeric stereospecificity, and their potential impact on modifying and hopefully improving energy production in ischemic tissue. Studies to evaluate the impact of coronary washout on preserving metabolic and mechanical functions are also planned. Studies will determine whether washout in ischemia alters vascular redistribution and oxygen content. It is hoped that a critical evaluation of cardiac metabolism and energy production with these several interventions will provide insights to possible future therapeutic options for protecting ischemic myocardium.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL032350-07
Application #
3343743
Study Section
Cardiovascular and Pulmonary Research A Study Section (CVA)
Project Start
1984-01-01
Project End
1990-12-31
Budget Start
1990-01-01
Budget End
1990-12-31
Support Year
7
Fiscal Year
1990
Total Cost
Indirect Cost
Name
University of Wisconsin Madison
Department
Type
Schools of Medicine
DUNS #
161202122
City
Madison
State
WI
Country
United States
Zip Code
53715
Hacker, T A; Renstrom, B; Nellis, S H et al. (1998) The role of glucose metabolism in a pig heart model of short-term hibernation. Mol Cell Biochem 180:75-83
Hacker, T A; Renstrom, B; Nellis, S H et al. (1997) Effect of repetitive stunning on myocardial metabolism in pig hearts. Am J Physiol 273:H1395-402
Liedtke, A J; Hacker, T; Renstrom, B et al. (1996) Anaplerotic effects of propionate on oxidations of acetate and long-chain fatty acids. Am J Physiol 270:H2197-203
Renstrom, B; Liedtke, A J (1995) Adjustments in competitive substrate utilization in stunned myocardium during early reperfusion. Basic Res Cardiol 90:279-81
Liedtke, A J; Renstrom, B; Nellis, S H et al. (1995) Mechanical and metabolic functions in pig hearts after 4 days of chronic coronary stenosis. J Am Coll Cardiol 26:815-25
Liedtke, A J; Renstrom, B; Hacker, T A et al. (1995) Effects of moderate repetitive ischemia on myocardial substrate utilization. Am J Physiol 269:H246-53
Liedtke, A J; Renstrom, B; Nellis, S H et al. (1994) Myocardial function and metabolism in pig hearts after relief from chronic partial coronary stenosis. Am J Physiol 267:H1312-9
Bolukoglu, H; Liedtke, A J; Nellis, S H et al. (1992) An animal model of chronic coronary stenosis resulting in hibernating myocardium. Am J Physiol 263:H20-9
Bolukoglu, H; Eggleston, A M; Subramanian, R et al. (1991) Effects of propionyl-L-carnitine in chronically hypoperfused (""hibernating"") myocardium. Cardioscience 2:245-55
Molaparast-Saless, F; Shrago, E; Spennetta, T L et al. (1988) Determination of individual long-chain fatty acyl-CoA esters in heart and skeletal muscle. Lipids 23:490-2